First, we observed that BMI, waist or insulin attenuated the relationship between IGR categories to a fairly similar small extent and that adjusting for these factors altogether did not add substantial adjustment as compared to adjustment based on any of the three markers alone.
However, the attenuation of the relation between CVD risk factors and IGR categories was only marginally larger upon adjustment with all three adiposity/insulin resistance markers (BMI, waist, insulin) as compared to adjustment for any of these markers.
However, at four years, SP-D was still lower in RA patients as compared to controls with adjustment for confounders (P < 0.001).
For all retained papers, detailed data were extracted including HR (95% CI) for current smoking as compared to never smokers, adjustment variables and variables used for stratified analyses.
Serum sirtuins (SIRT1, 2 and 3) were significantly lower in frails as compared to nonfrail after adjustment for multiple confounders such as age, gender, diabetes mellitus, hypertension, cognitive impairment, and number of comorbidities.
Odds Ratio of IDH for Group 6 was 0.47 (95% CI 0.25 to 0.88) as compared to Group 1 after adjustment.
There are 18.9 times as many hog operations in the highest quintile of poverty as compared to the lowest; however, adjustment for population density reduces the excess to 7.2.
Significantly higher plasma levels of TIMP-1 [β = 0.27 SD (95%CI: 0.06; 0.48)] were observed in individuals with CVD (n = 118) as compared to those without, after adjustment for age, sex, duration of diabetes and HbA1c (Additional file 1: Table S1, Model 1).
The Null Model Likelihood Ratio Test (SAS ver. 9.4; SAS Institute, Cary, NC) indicated that the Q-K model significantly (P ≤ 0.005) improved the description of variance between genotypes in all environments as compared to a model without adjustment for genetic relatedness.
An improvement of the fit was determined by the percentage reduction of the residual variance (unexplained variation) for the model with adjustment as compared to the one without.
AD participants were treated with a significantly higher number of drugs as compared to cognitively healthy controls, even after adjustment for co-morbidity.
